Currently there are no approved drug delivery method for gene therapy
R&D Focus
DNA-based nanodevices
Innovative Solution
DNA Nanobots uses its IP to create products for targeted chemotherapies, vaccines, point-of-care diagnostics, and functionalized gene delivery
Solution Effectiveness
DNA Nanobots creates targeted therapeutics delivery using its DNA nanoparticle platform
Investment Funding
Startup Stage
Early-Stage
People
Founders
Patrick Halley
Christopher Lucas Ph.D
Carlos Castro
Jeffrey Spitzner
CEO
Jeffrey Spitzner
Products
Demo Product or Complete Product?
Development
Awards and Recognitions
Media Apperance
GreyB
M&A and Collabs
Collab
DNA Nanobots Gains Exclusive License to UC Berkeley Gene Editing Technology Platform for Non-Viral Gene Delivery Solution using DNA Nanoparticles and CRISPR-Cas
